143 related articles for article (PubMed ID: 38436725)
1. Reactivation of Epstein-Barr virus among intensive care patients: a prospective observational study.
Guiouillier F; Derely J; Salvadori A; Pochard J; Le Goff J; Martinez T; Raffin F; Laitselart P; Beaucreux C; Priou S; Conan PL; Foissaud V; Servonnet A; Vest P; Boutonnet M; de Rudnicki S; Bigaillon C; Libert N
Intensive Care Med; 2024 Mar; 50(3):418-426. PubMed ID: 38436725
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus reactivation in critically ill immunocompetent patients.
Libert N; Bigaillon C; Chargari C; Bensalah M; Muller V; Merat S; de Rudnicki S
Biomed J; 2015; 38(1):70-6. PubMed ID: 25179711
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit.
Coşkun O; Yazici E; Şahiner F; Karakaş A; Kiliç S; Tekin M; Artuk C; Yamanel L; Beşirbellioğlu BA
Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):239-245. PubMed ID: 27435067
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients.
Naendrup JH; Garcia Borrega J; Eichenauer DA; Shimabukuro-Vornhagen A; Kochanek M; Böll B
J Intensive Care Med; 2022 Sep; 37(9):1152-1158. PubMed ID: 34791940
[TBL] [Abstract][Full Text] [Related]
6. Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation.
Li SS; Zhang N; Jia M; Su M
Front Cell Infect Microbiol; 2022; 12():818167. PubMed ID: 35402291
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
[TBL] [Abstract][Full Text] [Related]
8. Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen.
Ru Y; Zhu J; Song T; Ding Y; Zhu Z; Fan Y; Xu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu C; Chen S; Ma X; Chen F; Chen J; Wu D
Front Cell Infect Microbiol; 2022; 12():865170. PubMed ID: 35651756
[TBL] [Abstract][Full Text] [Related]
9. Differential Reactivation of Cytomegalovirus and Epstein-Barr Virus in Patients with B Cell Lymphoma.
Hatayama Y; Watanabe K; Ichikawa H; Kawamura K; Fukuda T; Motokura T
Viral Immunol; 2023 Oct; 36(8):520-525. PubMed ID: 37440168
[TBL] [Abstract][Full Text] [Related]
10. Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.
Park SS; Cho SY; Han E; Min GJ; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW
Eur J Haematol; 2019 Oct; 103(4):433-441. PubMed ID: 31381187
[TBL] [Abstract][Full Text] [Related]
11. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19.
Simonnet A; Engelmann I; Moreau AS; Garcia B; Six S; El Kalioubie A; Robriquet L; Hober D; Jourdain M
Infect Dis Now; 2021 May; 51(3):296-299. PubMed ID: 33495765
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation.
Hu J; Zhao J; Wang C; Jia M; Su M; Li S
Ann Hematol; 2023 Dec; 102(12):3593-3601. PubMed ID: 37831153
[TBL] [Abstract][Full Text] [Related]
13. Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation.
Carpenter B; Haque T; Dimopoulou M; Atkinson C; Roughton M; Grace S; Denovan S; Fielding A; Kottaridis PD; Griffiths P; Mackinnon S; Emery V; Chakraverty R
Transplantation; 2010 Sep; 90(5):564-70. PubMed ID: 20555307
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
Frantzeskaki FG; Karampi ES; Kottaridi C; Alepaki M; Routsi C; Tzanela M; Vassiliadi DA; Douka E; Tsaousi S; Gennimata V; Ilias I; Nikitas N; Armaganidis A; Karakitsos P; Papaevangelou V; Dimopoulou I
J Crit Care; 2015 Apr; 30(2):276-81. PubMed ID: 25457114
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation.
Xie Y; Cao S; Dong H; Lv H; Teng X; Zhang J; Wang T; Zhang X; Qin Y; Chai Y; Yang L; Liu J; Wang R
BMC Infect Dis; 2021 Sep; 21(1):955. PubMed ID: 34525962
[TBL] [Abstract][Full Text] [Related]
16. Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab.
Gill H; Hwang YY; Chan TS; Pang AW; Leung AY; Tse E; Kwong YL
J Clin Virol; 2014 Apr; 59(4):255-8. PubMed ID: 24507802
[TBL] [Abstract][Full Text] [Related]
17. High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia.
Ogata M; Satou T; Kawano R; Yoshikawa T; Ikewaki J; Kohno K; Ando T; Miyazaki Y; Ohtsuka E; Saburi Y; Kikuchi H; Saikawa T; Kadota J
J Med Virol; 2011 Apr; 83(4):702-9. PubMed ID: 21328386
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and reactivation of latent herpesviruses in older adults.
Bennett JM; Glaser R; Malarkey WB; Beversdorf DQ; Peng J; Kiecolt-Glaser JK
Brain Behav Immun; 2012 Jul; 26(5):739-46. PubMed ID: 22155500
[TBL] [Abstract][Full Text] [Related]
19. Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: A systematic review of the literature.
Anderson-Smits C; Baker ER; Hirji I
Transpl Infect Dis; 2020 Dec; 22(6):e13396. PubMed ID: 32603496
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]